Fresenius Medical Care AG & Co. KGaA (ADR) (NYSE:FMS)

CAPS Rating: 5 out of 5

The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.

Recs

0
Player Avatar smoke14 (< 20) Submitted: 6/5/2009 1:31:24 PM : Outperform Start Price: $41.04 FMS Score: +21.96

Dialysis treatment will continue to expand

Featured Broker Partners


Advertisement